Table 2.
Comparison between healthy sites and diseased sites
| Clinical and biochemical parameters | Sites | Mean ± SD | First quartile | Median | Third quartile |
|---|---|---|---|---|---|
| PlI | Healthy sites | 0.1 ± 0.4 | 0.0 | 0.0 | 0.0 |
| Diseased sites | 0.6 ± 0.7*** | 0.0 | 0.0 | 1.0 | |
| GCF amount (μl/pocket) | Healthy sites | 0.5 ± 0.3 | 0.2 | 0.3 | 0.6 |
| Diseased sites | 1.3 ± 0.8*** | 0.6 | 1.1 | 1.7 | |
| PD (mm) | Healthy sites | 2.1 ± 0.7 | 2.0 | 2.0 | 2.0 |
| Diseased sites | 4.9 ± 1.1*** | 4.0 | 5.0 | 5.5 | |
| CAL (mm) | Healthy sites | 3.1 ± 1.5 | 2.0 | 3.0 | 4.0 |
| Diseased sites | 6.6 ± 2.1*** | 5.0 | 6.0 | 8.0 | |
| GI | Healthy sites | 0.2 ± 0.4 | 0.0 | 0.0 | 0.0 |
| Diseased sites | 1.3 ± 0.7*** | 1.0 | 1.0 | 2.0 | |
| ABR ratio (%) | Healthy sites | 15.2 ± 19.0 | 0.0 | 9.2 | 27.9 |
| Diseased sites | 47.0 ± 23.4*** | 28.8 | 44.1 | 66.4 | |
| ALP activity (μU/pocket) | Healthy sites | 78.4 ± 129.6 | 19.3 | 30.8 | 80.5 |
| Diseased sites | 445.7 ± 849.6*** | 39.0 | 127.5 | 386.1 | |
| Protein amount (μg/pocket) | Healthy sites | 14.0 ± 10.3 | 6.1 | 11.6 | 19.1 |
| Diseased sites | 33.0 ± 25.5*** | 16.1 | 25.3 | 39.0 | |
| Hb amount (ng/pocket) | Healthy sites | 51.2 ± 48.8 | 7.4 | 35.7 | 86.8 |
| Diseased sites | 86.5 ± 43.9*** | 53.6 | 96.6 | 119.7 |
Healthy sites PD ≤ 4 mm, BOP (−); n = 76
Diseased sites PD ≥ 4 mm, BOP (+); n = 76
***P < 0.001 versus healthy sites